Evidence-based traditional Chinese medicine: present and future_Chinese Journal of Evidence-Based Medicine

Authors：

ZHANG Junhua ¹ , SUN Xin ² ,  LI Youping ² ,  ZHANG Boli ¹

1. Evidence-Based Medicine Centre, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, P.R.China;
2. Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;

Corresponding author：

LI Youping, Email: yzmylab@hotmail.com; ZHANG Boli, Email: zhangbolipr@163.com

Keywords：

DOI：

10.7507/1672-2531.201904053

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Evidence-based Chinese medicine (EBCM) is one of the innovative achievements in the development of evidence-based medicine (EBM) in China. The EBCM has made initial progress: the evidence-based scientific decision-making model has become popular; a series of key technologies for evidence-based evaluation and research of traditional Chinese medicine (TCM) have been established; several technical specifications have been formulated in line with international standards; clinical evidence database of TCM has been established; a number of high quality clinical trials have been published in internationally renowned journals; and the International Forum on Evidence based Chinese Medicine(EBCM) has become a brand conference. Difficulties in EBCM development mainly involve: lack of high quality clinical evidence, difficulty in producing evidence, and decentralization of research team. Based on opportunities and challenges of the development of TCM, this article proposed the short-term and long-term goals, implementation paths and five key directions for the development of EBCM in the future, and puts forward three suggestions for further development of EBCM.

Citation： ZHANG Junhua, SUN Xin, LI Youping, ZHANG Boli. Evidence-based traditional Chinese medicine: present and future. Chinese Journal of Evidence-Based Medicine, 2019, 19(5): 515-520. doi: 10.7507/1672-2531.201904053 Copy

1.	张伯礼. 面向未来: 世界需要中医药. 医学争鸣, 2016, 7(1): 1-4.
2.	张俊华, 李幼平, 张伯礼. 循证中医药学: 理论与实践. 中国中药杂志, 2018, 43(1): 1-7.
3.	国家卫生健康委员会. 《2017年中国卫生事业发展统计公报》. 2018-6-12.
4.	张伯礼, 张俊华, 陈士林, 等. 中药大健康产业发展机遇与战略思考. 中国工程科学, 2017, 19(2): 16-20.
5.	中华人民共和国国务院新闻办公室. 《中国的中医药》, 2016年12月.
6.	Cyranoski D. Why Chinese medicine is heading for clinics around the world. Nature, 2018, 561: 448-450.
7.	赖世隆, 胡镜清, 郭新峰. 循征医学与中医药临床研究. 广州中医药大学学报, 2000, 17(1): 1-8.
8.	Available at: https://www.nature.com/articles/d41586-018-04886-8.
9.	Ng AWT, Poon SL, Huang MN, et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci Transl Med, 2017, 9(412): pii: eaan6446.
10.	Chan M. WHO Director-General addresses traditional medicine forum. Available at: https://www.who.int/dg/speeches/2015/traditional-medicine/en/.
11.	Evidence-Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA, 1992, 268(17): 2420-2425.
12.	Medical milestones. https://www.bmj.com/content/medical-milestones.
13.	李幼平, 李静, 孙鑫, 等. 循证医学在中国的起源与发展: 献给中国循证医学20周年. 中国循证医学杂志, 2016, 16(1): 2-6.
14.	喻佳洁, 李琰, 陈雯雯, 李幼平. 从循证医学到循证科学的必然趋势. 中国循证医学杂志, 2019, 19(1): 119-124.
15.	第一届循证中医药学国际论坛在天津召开. 中医杂志, 2016, 57(13): 1165.
16.	张俊华, 孙鑫. 循证中医药学. 上海: 上海科技出版社, 2018.
17.	邢冬梅, 张俊华, 张伯礼. 中医临床研究核心结局指标集形成路径. 中华中医药杂志, 2014, 29(5): 1352-1355.
18.	张明妍, 张俊华, 杜亮, 等. 核心指标集研制规范(COS-STAD)介绍及其在中医药领域应用的思考. 中国循证医学杂志, 2018, 18(4): 392-396.
19.	邢冬梅. 中医药临床研究药物依从性测评方法研究. 天津:天津中医药大学, 2014.
20.	杨丰文, 田金徽, 张俊华, 等. 中医药网状Meta分析方法及要点. 中医杂志, 2017, 58(10): 841-844.
21.	刘保延. 真实世界的中医临床科研范式. 中医杂志, 2013, 54(6): 451-455.
22.	张俊华, 任经天, 胡镜清, 等. 中药注射剂临床安全性集中监测研究设计与实施专家共识. 中国中药杂志, 2017, 42(1): 6-9.
23.	陈吉, 孙月, 布优祥, 等. 中医领域真实世界研究现状分析. 中国循证医学杂志, 2018, 18(11): 1216-1223.
24.	张冬, 张俊华, 郑文科, 等. 中药临床安全性研究注册平台(CSRP)的构建. 世界科学技术-中医药现代化, 2016, 18(12): 2097-2100.
25.	MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med, 2010, 7(6): e1000261.
26.	Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration. Ann Intern Med, 2017, 167(2): 112-121.
27.	中医药临床证据数据库. Available at: http://tcmevd.com/evidence/index.
28.	中药注射剂临床有效性证据指数发布. Available at: http://www.xinhuanet.com/health/2018-10/15/c_1123560857.htm.
29.	Shang H, Zhang J, Yao C, et al. Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. Evid Based Complement Alternat Med, 2013, 2013: 738391.
30.	Li X, Zhang J, Huang J, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. J Am Coll Cardiol, 2013, 62(12): 1065-1072.
31.	Wang C, Cao B, Liu QQ, et al. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med, 2011, 155(4): 217-225.
32.	Liu Z, Yan S, Wu J, et al. Acupuncture for chronic severe functional constipation: a randomized trial. Ann Intern Med, 2016, 165(11): 761-769.
33.	Liu Z, Liu Y, Xu H, et al. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA, 2017, 317(24): 2493-2501.
34.	李慧, 陈耀龙, 杜亮, 等. 促进循证中医药指南制定的策略与建议: 广州宣言. 中国循证医学杂志, 2016, 16(7): 745-748.
35.	蒋跃绒, 陈可冀. 关于中医药循证临床实践指南的制定和质量评价. 中国中西医结合杂志, 2016, 36(1): 11-15.
36.	中国循证医学发展迈向新时代. Available at: http://health.gmw.cn/2018-10/13/content_31684389.htm.
37.	张明妍, 杨丰文, 李越, 等. 《中国中西医结合杂志》刊载中医药随机对照试验报告质量的研究. 中国循证医学杂志, 2017, 17(3): 357-363.
38.	国家中医药管理局. Available at: http://bgs.satcm.gov.cn/gongzuodongtai/2019-03-15/9319.html.
39.	张俊华, 孙鑫, 杜亮, 等. " 新时代循证医学发展”天津宣言. 中国循证医学杂志, 2018, 18(10): 1017.

1. 张伯礼. 面向未来: 世界需要中医药. 医学争鸣, 2016, 7(1): 1-4.
2. 张俊华, 李幼平, 张伯礼. 循证中医药学: 理论与实践. 中国中药杂志, 2018, 43(1): 1-7.
3. 国家卫生健康委员会. 《2017年中国卫生事业发展统计公报》. 2018-6-12.
4. 张伯礼, 张俊华, 陈士林, 等. 中药大健康产业发展机遇与战略思考. 中国工程科学, 2017, 19(2): 16-20.
5. 中华人民共和国国务院新闻办公室. 《中国的中医药》, 2016年12月.
6. Cyranoski D. Why Chinese medicine is heading for clinics around the world. Nature, 2018, 561: 448-450.
7. 赖世隆, 胡镜清, 郭新峰. 循征医学与中医药临床研究. 广州中医药大学学报, 2000, 17(1): 1-8.
8. Available at: https://www.nature.com/articles/d41586-018-04886-8.
9. Ng AWT, Poon SL, Huang MN, et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci Transl Med, 2017, 9(412): pii: eaan6446.
10. Chan M. WHO Director-General addresses traditional medicine forum. Available at: https://www.who.int/dg/speeches/2015/traditional-medicine/en/.
11. Evidence-Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA, 1992, 268(17): 2420-2425.
12. Medical milestones. https://www.bmj.com/content/medical-milestones.
13. 李幼平, 李静, 孙鑫, 等. 循证医学在中国的起源与发展: 献给中国循证医学20周年. 中国循证医学杂志, 2016, 16(1): 2-6.
14. 喻佳洁, 李琰, 陈雯雯, 李幼平. 从循证医学到循证科学的必然趋势. 中国循证医学杂志, 2019, 19(1): 119-124.
15. 第一届循证中医药学国际论坛在天津召开. 中医杂志, 2016, 57(13): 1165.
16. 张俊华, 孙鑫. 循证中医药学. 上海: 上海科技出版社, 2018.
17. 邢冬梅, 张俊华, 张伯礼. 中医临床研究核心结局指标集形成路径. 中华中医药杂志, 2014, 29(5): 1352-1355.
18. 张明妍, 张俊华, 杜亮, 等. 核心指标集研制规范(COS-STAD)介绍及其在中医药领域应用的思考. 中国循证医学杂志, 2018, 18(4): 392-396.
19. 邢冬梅. 中医药临床研究药物依从性测评方法研究. 天津:天津中医药大学, 2014.
20. 杨丰文, 田金徽, 张俊华, 等. 中医药网状Meta分析方法及要点. 中医杂志, 2017, 58(10): 841-844.
21. 刘保延. 真实世界的中医临床科研范式. 中医杂志, 2013, 54(6): 451-455.
22. 张俊华, 任经天, 胡镜清, 等. 中药注射剂临床安全性集中监测研究设计与实施专家共识. 中国中药杂志, 2017, 42(1): 6-9.
23. 陈吉, 孙月, 布优祥, 等. 中医领域真实世界研究现状分析. 中国循证医学杂志, 2018, 18(11): 1216-1223.
24. 张冬, 张俊华, 郑文科, 等. 中药临床安全性研究注册平台(CSRP)的构建. 世界科学技术-中医药现代化, 2016, 18(12): 2097-2100.
25. MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med, 2010, 7(6): e1000261.
26. Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration. Ann Intern Med, 2017, 167(2): 112-121.
27. 中医药临床证据数据库. Available at: http://tcmevd.com/evidence/index.
28. 中药注射剂临床有效性证据指数发布. Available at: http://www.xinhuanet.com/health/2018-10/15/c_1123560857.htm.
29. Shang H, Zhang J, Yao C, et al. Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. Evid Based Complement Alternat Med, 2013, 2013: 738391.
30. Li X, Zhang J, Huang J, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. J Am Coll Cardiol, 2013, 62(12): 1065-1072.
31. Wang C, Cao B, Liu QQ, et al. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med, 2011, 155(4): 217-225.
32. Liu Z, Yan S, Wu J, et al. Acupuncture for chronic severe functional constipation: a randomized trial. Ann Intern Med, 2016, 165(11): 761-769.
33. Liu Z, Liu Y, Xu H, et al. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA, 2017, 317(24): 2493-2501.
34. 李慧, 陈耀龙, 杜亮, 等. 促进循证中医药指南制定的策略与建议: 广州宣言. 中国循证医学杂志, 2016, 16(7): 745-748.
35. 蒋跃绒, 陈可冀. 关于中医药循证临床实践指南的制定和质量评价. 中国中西医结合杂志, 2016, 36(1): 11-15.
36. 中国循证医学发展迈向新时代. Available at: http://health.gmw.cn/2018-10/13/content_31684389.htm.
37. 张明妍, 杨丰文, 李越, 等. 《中国中西医结合杂志》刊载中医药随机对照试验报告质量的研究. 中国循证医学杂志, 2017, 17(3): 357-363.
38. 国家中医药管理局. Available at: http://bgs.satcm.gov.cn/gongzuodongtai/2019-03-15/9319.html.
39. 张俊华, 孙鑫, 杜亮, 等. " 新时代循证医学发展”天津宣言. 中国循证医学杂志, 2018, 18(10): 1017.

Previous Article
From evidence-based medicine to evidence-based science: the connotation and thinking
Next Article
Using real-world evidence for drug and medical device evaluation and regulatory decisions

Chinese Journal of Evidence-Based Medicine

Evidence-based traditional Chinese medicine: present and future

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content